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Attention, learning, and perceptual problems have been reported at various 
degrees and rates in neurofibromatosis type 1 (NF1). We aimed to define the 
cognitive profiles frequently associated with NF1. Children and adolescents 
with NF1 (n=58) were tested using Wechsler Intelligence Scales for Children-
Revised (WISC-R), Judgment of Line Orientation, and Bender Visual-Motor 
Gestalt tests. Comparison groups were unaffected siblings of NF1 patients 
(n=20), children with attention deficit and hyperactivity disorder (ADHD, 
n=40), and normal children (n=40). No difference was found between 
familial or sporadic NF1 cases. Seventeen/58 (29%) of NF1 cases had a full 
scale IQ <70. The subgroup of NF1 patients with full scale IQ>80 (n=27) 
scored lower in WISC-R subtests measuring visual perception when compared 
to a healthy control group of similar intelligence, and lower in arithmetic 
but better in Bender-Gestalt and Judgment of Line Orientation tests when 
compared to an ADHD group of similar intelligence. These results indicate a 
high prevalence of mental retardation in a clinical NF1 series. NF1 patients 
who have normal intelligence may have impaired visual perception, but 
their visual perceptual problems are less than in ADHD. The tendency of 
unaffected siblings of NF1 patients to have mildly but consistently low test 
scores compared to healthy controls needs to be studied further for underlying 
genetic or environmental factors.
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Neurofibromatosis type 1 (NF1) is a neuro-
cutaneous disorder with a prevalence of 1 in 
3,000-4,000. Forty-80% of children with NF1 
have some form of cognitive or behavioral 
impairment1,2. Mental retardation, defined as 
full scale intelligence quotient (FSIQ) <70, is 
only slightly higher in children with NF1 than 
in the general population, but discrepancies 
between Verbal IQ (VIQ) and Performance IQ 
(PIQ) in both directions2-4, and impairment in 
visual–spatial functions, spatial memory, and 
visual–motor integration skills, as illustrated 
by poorer performance in Bender Visual-Motor 
Gestalt (BG) and Judgment of Line Orientation 
(JLO) tests5,6, appear among the most common 
neuropsychological deficits.
Learning disabilities (LDs) have been reported 
in 30-60% of NF1 patients1,5. Of these, most 
are visual–perceptual (i.e., nonverbal) LD. 
Cutting et al.7 compared the nature of LD in 
NF1 with LD in the general population. The 
NF1 group scored significantly lower than 
the “developmental LD” group on visual–
spatial measures, suggesting more severe 
impairment. Up to 40% of children with 
NF1 also have problems with attention or 
impulse control, meeting the diagnostic criteria 
of attention deficit–hyperactivity disorder 
(ADHD)3. Attention problems may affect 
school performance in NF1: children with NF1 
who have at least one ADHD feature were 
more likely to repeat grades at school8.
Comparison between studies is limited by 
differences in study design, in definitions for terms 
like “specific learning disability”, and because of 
population biases caused by inclusion of patients 
with intracranial pathology, recruitment of 
patients from LD clinics, or the choice of control 
groups. Most studies investigated cognition in 
mixed groups of familial and sporadic NF1 
cases, using their unaffected siblings as the 
control group. Although the somatic phenotype 
and genetic mutations described in familial 
and sporadic NF1 are similar, the number of 
affected family members might influence the 
cognitive profile. In this study, we intended to 
examine cognition in children with familial and 
sporadic NF1 through a multivariate combination 
of three neuropsychological tests: Wechsler 
Intelligence Scales for Children-Revised (WISC-
R), Bender Visual-Motor Gestalt (BG), and the 
Judgment of Line Orientation (JLO), and to make 
comparisons with unaffected siblings, children 
with ADHD, and normal children.
Material and Methods
Participants (Table I)
A total of 158 children were included in this 
study: children with NF1 and a parent with 
the disease (NF1-familial, n=29), children with 
NF1 and no other affected family members 
(NF1-sporadic, n=29), unaffected siblings of 
children with NF1 (NF1-sib, n=20), children 
with ADHD (n=40), and children with no 
neurological problems (control, n=40). The 
diagnosis of NF1 was made according to the 
criteria of the National Institutes of Health9. 
Children with central nervous system or 
other systemic conditions that may affect test 
performance, such as epilepsy and brain tumors, 
were excluded. Children with stable optic 
glioma and no visual impairment were included. 
The unaffected siblings of children with NF1 
were examined by a child neurologist and an 
ophthalmologist to rule out NF1; when there 
was more than one sib in the family, the sibling 
of closest age was included in the study.
The ADHD group consisted of newly diagnosed 
children according to the Diagnostic and 
Statistical Manual (DSM-IV)10. Neurological 
and systemic disorders, children on medication 
and those with uncorrected hearing or visual 
problems were excluded. In order to screen 
for comorbidities and support the diagnosis 
of ADHD, the Kiddie-Schedule for Affective 
Disorders and Schizophrenia - Present and 
Lifetime Version (K-SADS-PL) Diagnostic 
Interview, a structured interview formed 
to detect a wide array of past and present 
psychopathology in children and adolescents 
Table I. Characteristics of Research Groups
Patient groups Sex N Age range (years) Mean age
NF1 cases
 IQ<79
F 15 7-23 12.4
M 16 8-22  8.4
 IQ≥80 F 14 8-23 11.1
M 13 7-15 10.5
 Familial F 15 8-23 12.5
M 14 7-15 11.1
 Sporadic F 14 7-20 11.9
M 15 8-24 12.4
Unaffected siblings of NF1 F 16 7-19 13.2
M  4 7-14  9.5
ADHD F 20 8-13  9.8
M 20 7-13 10.2
Control F 20 8-14 10.1
M 20 8-13 10.2
NF: Neurofibromatosis. IQ: Intelligence quotient. ADHD: Attention deficit hyperactivity disorder.
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according to DSM-III and DSM-IV criteria11,12, 
and Conners Parent and Teachers’ Rating 
Scales13-16, all adapted and validated for Turkey, 
were applied.
The healthy control group consisted of 
volunteering age-matched children with no 
known health or learning problems from schools 
and well-child clinics in the same district. 
Patients with undiagnosed or unreported LD in 
the ADHD and control groups were excluded if 
deficits in one of these criteria were observed: 
discrepancy between VIQ and PIQ exceeding 15 
points on the WISC-R profile, DSM-IV criteria 
for ADHD and LD, or a previously validated 
standard quiz assessing the reading, writing 
and mathematic skills appropriate for the 
child’s age and grade17. Socioeconomic status 
was assessed as “low” or “middle and high” 
in all groups according to parental education 
and income. Signed informed consent from 
the parents and assent from all subjects were 
obtained. The study was approved by the 
institutional ethics committee.
Neuropsychological Tests
1. Wechsler Intelligence Scales for Children-
Revised (WISC-R):
This is an intelligence test for children between 
the ages of 6-16 that can be completed without 
reading or writing. It consists of two scales, 
the Verbal and Performance Scales, each 
with several subtests18. The Verbal Scale 
measures language expression, comprehension, 
listening, and the ability to apply these skills 
to solve problems. The examiner asks the 
questions orally and the child gives a spoken 
response. We used five verbal subtests 
of the WISC-R: Information, Similarities, 
Arithmetic, Comprehension, and Digit Span. 
The Performance Scale assesses nonverbal 
problem solving, perceptual organization, 
speed, and visual-motor proficiency. Included 
are tasks like puzzles, analysis of pictures, 
imitating designs with blocks, and copying. We 
used five performance subtests of the WISC-
R: Picture Completion, Picture Arrangement, 
Block Design, Object Assembly, and Coding. 
The VIQ and PIQ obtained from the test are the 
summary measures of verbal and performance 
skills, and the FSIQ, based on the 10 tests 
included in the VIQ and PIQ scales, is an index 
of general intellectual functioning.
The WISC-R was adapted and standardized in 
Turkey in 1997. A few items were changed, 
but in general the Turkish version closely 
resembles the original version. Approximately 
11 age groups (6-16 years) constituted the 
standardization sample. Test-retest reliabilities 
were 0.97 for VIQ, 0.93 for PIQ, and 0.97 
for FSIQ. Subtest reliabilities ranged between 
0.51-0.8619.
2. The Bender Visual-Motor Gestalt Test (BG):
This is a psychological assessment used to 
evaluate visual-motor functioning, visual-
perceptual skills, neurological and emotional 
disturbances, and mostly functions of the 
non-dominant parietal lobe, in individuals aged 
three and older. It is also used to evaluate 
visual-motor maturity and to screen children for 
developmental delays20. Test-retest reliabilities 
in the Turkish standardization ranged from 
0.73- 0.9721. Impairment in the listed functions 
is associated with high scores.
3. The Judgment of Line Orientation
 (JLO) Test:
Judgment of Line Orientation (JLO) is an 
assessment of visual recognition and visual-
spatial functioning in subjects aged three and 
older. It measures the functions of the non-
dominant cerebral hemisphere and mostly 
parietal lobe22. Its standardization for Turkey 
was done with test-retest reliabilities of 0.8523. 
Impairment in the listed functions is associated 
with low scores.
Statistical Analysis
The Statistical Package for the Social Sciences 
(Windows version 13) multivariate analysis of 
covariance (MANCOVA) was used to compare 
the scores of each test and subtest between 
groups. Specific differences were examined 
with Bonferroni adjustment, using a p value of 
<0.05 as significant. The reasons for the choice 
of MANCOVA were the continuous nature 
of our dependent variables (test scores), the 
number of dependent variables, multiple levels 
of independent variables, and the possibility to 
take socioeconomic status into consideration.
Results
Neurofibromatosis (NF1)-familial and NF1-
sporadic patients had similar scores on all 
tests and were combined in one single group 
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for further analysis. Five children with NF1 
and optic glioma showed no particular deficit 
in tests requiring visual input, and were not 
excluded from the group. NF1-sibs from 
familial and sporadic NF1 groups did not differ 
in VIQ, PIQ and FSIQ (p=0.31).
Mental deficiency: FSIQ <70 was seen in 
17/58 patients (29%), and FSIQ <79 in 31/58 
patients (53%). Only 10/58 NF1 patients 
had FSIQ >90, and the mean FSIQ of the 
NF1 group was 76.9, compared to 115.6 in 
control children. ANCOVA (socioeconomic 
status covariance variable) was used to test the 
difference between VIQ-PIQ. The differences 
were more pronounced in the NF1 than control 
groups (f: 3.70; p: 0.014). There were group 
differences in WISC-R subtests, VIQ, PIQ, 
FSIQ, BG Total Score, and JLO Total Score 
(Wilks lambda=0.13, p<0.0001), confirmed 
by post-hoc Tukey test analysis, demonstrating 
that children with NF1 performed significantly 
lower than controls in all WISC-R subtests.
In order to investigate specific impairments, 
groups with comparable IQ scores-NF1 patients 
with IQ ≥80 and ADHD and control patients 
with IQ between 80-120 - were evaluated. 
Multivariate analysis of variance showed that 
the group variable (NF1, NF1-sibling, ADHD, 
control) was significant (Wilks lambda=0.00, 
p<0.000). There were group differences in 
Arithmetic, Digit Span, Picture Completion, 
Block Design, Object Assembly, VIQ, PIQ, FSIQ, 
BG Total Score, and JLO Total Score. Post-hoc 
analysis (Bonferroni adjusted) demonstrated 
that children with NF1 performed significantly 
lower than controls in Arithmetic, Picture 
Completion, Block Design, and Object Assembly 
subtests of WISC-R, as well as in VIQ, PIQ, 
FSIQ, and JLO, and significantly lower than 
NF1-siblings in JLO. They scored better than 
the ADHD group in BG and JLO and lower in 
arithmetic (Table II). Six siblings and 8 NF1 
patients in the total group and 4 siblings and 
4 NF1 patients in the NF group with IQ>80 
met the criteria of ADHD.
NF1-siblings performed significantly lower 
than the control children in Block Design 
and JLO. They scored better than ADHD in 
BG and JLO.
Children with ADHD performed significantly 
lower than the control group in Arithmetic, 
Digit Span, Block Design, Object Assembly, 
VIQ, PIQ, FSIQ, BG, and JLO.
Discussion
Cognitive and behavioral impairment in NF1 
has been related to the brain parenchymal 
lesions on magnetic resonance imaging 
(MRI), abnormal corticogenesis and abnormal 
myelination2. Recently, the association of 
well-circumscribed T2-hyperintense lesions in 
the thalamus with cognitive impairment drew 
attention to the location of the parenchymal 
lesions24. Possible molecular mechanisms 
involving the functions of the neurofibromin 
protein may include increased Ras activity, 
increased GABA-mediated inhibition, or 
impaired vesicle trafficking25,26. However, a 
definite link between the genetic and cognitive 
mechanisms is lacking.
Children with NF1 had lower scores on many 
cognitive and visual perceptual tests compared 
to the control groups in our study. Mental 
retardation has been reported between 6-
11% in the literature2,27. The higher figures 
in our study (29% with FSIQ <70) may 
reflect the profile of a hospital population 
referred to a child neurology department at 
the tertiary-care level, or because previous 
studies classified most such children as LD3. 
The pattern of impairment did not show any 
particular feature: all subtest scores were lower 
than in control children, and no trend was 
observed for verbal or performance IQ being 
more affected. However, visual perceptual 
deficits were common: nearly all children with 
NF1, including those with normal FSIQ, had 
impairment in at least one visual test (visual 
perception, visual motor, visual memory). This 
is in agreement with impaired spatial memory 
and visual-spatial functioning observed in 
most studies, although certain series reported 
intact visual memory and selective attention1-3. 
Spared and impaired functions both in verbal 
and nonverbal domains of WISC-R have been 
reported: Picture Completion and Picture 
Arrangement were spared, while Vocabulary 
and Block Design subtests were impaired28.
Because the general intelligence level would 
affect comparisons between test results and 
groups, we controlled for IQ by analyzing NF1 
patients with normal FSIQ separately. Even with 
a FSIQ >80, NF1 children had lower scores 
than control children in Picture Completion, 
Block Design and Object Assembly, subtests 
related to spatial perception and organization. 
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Hyman et al.2 noted that many significant 
differences between NF1 and unaffected sibling 
controls disappeared when IQ was controlled 
for, but differences between NF1 and siblings 
persisted in the JLO and spatial relations 
tasks. The only domains in which deficits were 
greater than predicted by IQ were reading, 
spelling, planning, perception (visuospatial and 
visuoperceptual), and sustained attention. Our 
results also indicate that NF1 patients with 
normal IQ differ from controls in processing 
visual information. It appears important to 
control for IQ when diagnosing specific deficits 
in NF1, especially in hospital populations.
Neurofibromatosis-1 children scored lower than 
the ADHD group only in Arithmetic, and, as 
expected, better than ADHD in BG and JLO. 
Attention problems have often been reported 
in children with NF3,8: in our series, attention 
did not present as a frequent problem when 
IQ was controlled for. Although some children 
in the NF1 and NF-sib groups met the criteria 
for ADHD and the NF1 and ADHD groups 
scored similar in visual-spatial subtests, which 
have a clear relationship with attention, the 
ADHD group manifested more pronounced 
impairment in BG and JLO.
In contrast with most studies using siblings as 
the only control group, we compared NF-sibs to 
other control groups. There was no difference 
between NF1 with normal IQ and NF1-sibs 
except on the Block Design subtest. Interestingly, 
siblings of NF1 patients performed lower than 
healthy control children in almost all tests: 
although the differences were not significant, 
scores of the NF-sib group were consistently 
between NF1 and control values. Because our 
analyses were corrected for socioeconomic 
status and NF1 had been ruled out in these 
children through a detailed clinical evaluation 
done after 6 years of age (when the cutaneous 
stigmata of NF1 would be apparent), we can 
speculate on certain other mechanisms for 
this finding: biological causes involving genetic 
characteristics in the proximity of the NF1 
gene, or environmental causes, i.e., the effect 
of a sibling with NF1 and visual-perceptual 
problems, may be implicated. Children with 
NF1 have deficiencies in emotional adjustment 
and quality of life29. It is possible that NF1 
patients being followed-up in a hospital setting 
have more severe psychological impairment, 
rendering their siblings more susceptible 
to cognitive and attention problems. In any 
case, this finding questions the validity of 
control groups consisting of siblings of NF1 
patients used in various reports. More detailed 
studies including siblings from various ages, 
or comparisons between siblings according to 
birth order, might bring further information. 
Our results point to the degree and frequency 
of cognitive impairment in NF1 even in the 
presence of normal IQ and to the need for 
comprehensive assessment including family 
and home environments.
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